Patent Claims Potential for Facial Acne

10/28/2019: A skin serum topical application for reducing the bacteria that cause acne was discovered during a 2-year 4-phase study at Loma Linda Medical School. Studies on normal human skin showed a serum formulation that would reduce Cutibacterium acnes. The studies were performed with the purpose of creating a surgical disinfectant.

An United States patent was granted on this science: 9,925,152 Antimicrobials and methods of use thereof for wound healing. March 27, 2018.

This was a continuation of the parent application showing that this original formulation may add another metabolite to protocatechuic acid; 2,4,6 trihydroxybenzaldehyde.

Patent claims were granted in that both metabolites act as broad spectrum antibiotics, plus collagen proliferation (i.e. wrinkle treatment) and reduction in skin scar formation.

As such there would be a serum formulation for skin health:

Or dash to A dash cosmetic dot com.